Rodrigo Machado-Vieira1, David A Luckenbaugh1, Elizabeth D Ballard1, Ioline D Henter1, Mauricio Tohen1, Trisha Suppes1, Carlos A Zarate1. 1. From the Section on the Neurobiology and Treatment of Mood Disorders, NIMH, Bethesda, Md.; the Department of Psychiatry and Behavioral Sciences, Health Sciences Center, University of New Mexico, Albuquerque; VA Palo Alto Health Care System and the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, Calif.
Abstract
OBJECTIVE: DSM-5 describes "a distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased activity or energy" as a primary criterion for mania. Thus, increased energy or activity is now considered a core symptom of manic and hypomanic episodes. Using data from the Systematic Treatment Enhancement Program for Bipolar Disorder study, the authors analyzed point prevalence data obtained at the initial visit to assess the diagnostic validity of this new DSM-5 criterion. The study hypothesis was that the DSM-5 criterion would alter the prevalence of mania and/or hypomania. METHOD: The authors compared prevalence, clinical characteristics, validators, and outcome in patients meeting the DSM-5 criteria (i.e., DSM-IV criteria plus the DSM-5 criterion of increased activity or energy) and those who did not meet the new DSM-5 criterion (i.e., who only met DSM-IV criteria). RESULTS: All 4,360 participants met DSM-IV criteria for bipolar disorder, and 310 met DSM-IV criteria for a manic or hypomanic episode. When the new DSM-5 criterion of increased activity or energy was added as a coprimary symptom, the prevalence of mania and hypomania was reduced. Although minor differences were noted in clinical and concurrent validators, no changes were observed in longitudinal outcomes. CONCLUSIONS: The findings confirm that including increased activity or energy as part of DSM-5 criterion A decreases the prevalence of manic and hypomanic episodes but does not affect longitudinal clinical outcomes.
OBJECTIVE: DSM-5 describes "a distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased activity or energy" as a primary criterion for mania. Thus, increased energy or activity is now considered a core symptom of manic and hypomanic episodes. Using data from the Systematic Treatment Enhancement Program for Bipolar Disorder study, the authors analyzed point prevalence data obtained at the initial visit to assess the diagnostic validity of this new DSM-5 criterion. The study hypothesis was that the DSM-5 criterion would alter the prevalence of mania and/or hypomania. METHOD: The authors compared prevalence, clinical characteristics, validators, and outcome in patients meeting the DSM-5 criteria (i.e., DSM-IV criteria plus the DSM-5 criterion of increased activity or energy) and those who did not meet the new DSM-5 criterion (i.e., who only met DSM-IV criteria). RESULTS: All 4,360 participants met DSM-IV criteria for bipolar disorder, and 310 met DSM-IV criteria for a manic or hypomanic episode. When the new DSM-5 criterion of increased activity or energy was added as a coprimary symptom, the prevalence of mania and hypomania was reduced. Although minor differences were noted in clinical and concurrent validators, no changes were observed in longitudinal outcomes. CONCLUSIONS: The findings confirm that including increased activity or energy as part of DSM-5 criterion A decreases the prevalence of manic and hypomanic episodes but does not affect longitudinal clinical outcomes.
Authors: C L Bowden; R H Perlis; M E Thase; T A Ketter; M M Ostacher; J R Calabrese; N A Reilly-Harrington; J M Gonzalez; V Singh; A A Nierenberg; G S Sachs Journal: CNS Neurosci Ther Date: 2011-06-07 Impact factor: 5.243
Authors: Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; William Coryell; Jean Endicott; Jack D Maser; David A Solomon; Andrew C Leon; Martin B Keller Journal: Arch Gen Psychiatry Date: 2003-03
Authors: H S Akiskal; E G Hantouche; M L Bourgeois; J M Azorin; D Sechter; J F Allilaire; L Chatenêt-Duchêne; S Lancrenon Journal: J Affect Disord Date: 2001-12 Impact factor: 4.839
Authors: Arpi Minassian; Brook L Henry; Mark A Geyer; Martin P Paulus; Jared W Young; William Perry Journal: J Affect Disord Date: 2010-01 Impact factor: 4.839
Authors: Ralph W Kupka; Lori L Altshuler; Willem A Nolen; Trisha Suppes; David A Luckenbaugh; Gabriele S Leverich; Mark A Frye; Paul E Keck; Susan L McElroy; Heinz Grunze; Robert M Post Journal: Bipolar Disord Date: 2007-08 Impact factor: 6.744
Authors: Robert M Post; Gabriele S Leverich; Lori L Altshuler; Mark A Frye; Trisha M Suppes; Paul E Keck; Susan L McElroy; Ralph Kupka; Willem A Nolen; Heinz Grunze; Jorg Walden Journal: Bipolar Disord Date: 2003-10 Impact factor: 6.744
Authors: Elisabeth A Frazier; Jeffrey I Hunt; Heather Hower; Richard N Jones; Boris Birmaher; Michael Strober; Benjamin I Goldstein; Martin B Keller; Tina R Goldstein; Lauren M Weinstock; Daniel P Dickstein; Rasim S Diler; Neal D Ryan; Mary Kay Gill; David Axelson; Shirley Yen Journal: J Affect Disord Date: 2020-04-18 Impact factor: 4.839